Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 30001 - 30025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Deferoxamine	Approved Investigational	CYP3A4	1576	downregulated	Deferoxamine results in decreased expression of CYP3A4 mRNA	7q22.1	A22061
Deferoxamine	Approved Investigational	DICER1	23405	downregulated	Deferoxamine results in decreased expression of DICER1 mRNA	14q32.13	A22056
Deferoxamine	Approved Investigational	DNMT1	1786	downregulated	Deferoxamine results in decreased expression of DNMT1 mRNA	19p13.2	A22054
Deferoxamine	Approved Investigational	DNMT1	1786	upregulated	Deferoxamine results in increased expression of DNMT1 mRNA	19p13.2	A22054
Deferoxamine	Approved Investigational	DNMT3A	1788	downregulated	Deferoxamine results in decreased expression of DNMT3A mRNA	2p23.3	A22054
Deferoxamine	Approved Investigational	DNMT3A	1788	upregulated	Deferoxamine results in increased expression of DNMT3A mRNA	2p23.3	A22054
Deferoxamine	Approved Investigational	DNMT3B	1789	downregulated	Deferoxamine results in decreased expression of DNMT3B mRNA	20q11.21	A22054
Deferoxamine	Approved Investigational	DNMT3B	1789	upregulated	Deferoxamine results in increased expression of DNMT3B mRNA	20q11.21	A22054
Deferoxamine	Approved Investigational	EHMT2	10919	downregulated	Deferoxamine results in decreased expression of EHMT2 mRNA	6p21.33	A22054
Deferoxamine	Approved Investigational	ENO1	2023	upregulated	Deferoxamine results in increased expression of ENO1 mRNA	1p36.23	A22062
Deferoxamine	Approved Investigational	EPO	2056	upregulated	Deferoxamine results in increased expression of EPO mRNA	7q22.1	A22063
Deferoxamine	Approved Investigational	ERO1A	30001	upregulated	Deferoxamine results in increased expression of ERO1A mRNA	14q22.1	A22064
Deferoxamine	Approved Investigational	FABP4	2167	downregulated	Deferoxamine results in decreased expression of FABP4 mRNA	8q21.13	A22065
Deferoxamine	Approved Investigational	FTL	2512	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of FTL mRNA	19q13.33	A22066
Deferoxamine	Approved Investigational	GADD45A	1647	upregulated	Deferoxamine results in increased expression of GADD45A mRNA	1p31.3	A22058
Deferoxamine	Approved Investigational	GAS1	2619	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of GAS1 mRNA	9q21.33	A22066
Deferoxamine	Approved Investigational	GBE1	2632	upregulated	Deferoxamine results in increased expression of GBE1 mRNA	3p12.2	A22067
Deferoxamine	Approved Investigational	HIF1A	3091	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of HIF1A mRNA	14q23.2	A22066
Deferoxamine	Approved Investigational	HMOX1	3162	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HMOX1 mRNA	22q12.3	A22066
Deferoxamine	Approved Investigational	HMOX1	3162	downregulated	Deferoxamine results in decreased expression of HMOX1 mRNA	22q12.3	A22068
Deferoxamine	Approved Investigational	HSPA1L	3305	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA1L mRNA	6p21.33	A22066
Deferoxamine	Approved Investigational	HSPA9	3313	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA	5q31.2	A22066
Deferoxamine	Approved Investigational	HSPH1	10808	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPH1 mRNA	13q12.3	A22066
Deferoxamine	Approved Investigational	IL1B	3553	downregulated	Deferoxamine results in decreased expression of IL1B mRNA	2q14.1	A22069
Deferoxamine	Approved Investigational	JUN	3725	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of JUN mRNA	1p32.1	A22066

Displaying entries 30001 - 30025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability